(Press-News.org) New Rochelle, NY, July 11, 2013—Mosquito-borne dengue viruses cause an estimated 50 million cases of human dengue fever a year and are a significant public health threat worldwide. A novel therapeutic approach prevents dengue virus from reproducing in humans by targeting and silencing key regions of the dengue genome essential for viral replication. This innovative treatment strategy and the successful results of initial testing are presented in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers. The article is available on the Nucleic Acid Therapeutics website.
Pei-wen Xie, Yu Xie, Xiu-juan Zhang, Hai Huang, Li-na He, Xue-jun Wang, and Sheng-qi Wang, Beijing Institute of Radiation Medicine and Second Artillery General Hospital, Beijing, and Central South University, Changsha, China, identified multiple regions in the dengue virus genome that have maintained the same nucleic sequence over long periods of evolution. These highly conserved regions are ideal targets for antiviral drug development as they are unlikely to mutate and allow the virus to develop drug resistance.
In the article "Inhibition of Dengue Virus 2 Replication by Artificial MicroRNAs Targeting the Conserved Regions," the authors describe how they constructed artificial short strands of nucleic acids called microRNAs that specifically target these conserved sites in the dengue virus genome. Their experiments led to the identification of the most effective combinations of microRNAs capable of inhibiting the virus from replication in humans.
"The dengue virus is endemic in over 100 countries and spreading rapidly," says Executive Editor Fintan Steele, PhD, SomaLogic, Inc., Boulder, CO. "In the absence of effective preventive measures, new treatments like those being pursued by Xie et al. are desperately needed."
INFORMATION:
Nucleic Acid Therapeutics is under the editorial leadership of Co-Editors-in-Chief Bruce A. Sullenger, PhD, Duke Translational Research Institute, Duke University Medical Center, Durham, NC, and C.A. Stein, MD, PhD, City of Hope National Medical Center, Duarte, CA; and Executive Editor Fintan Steele, PhD (SomaLogic, Boulder, CO).
About the Journal
Nucleic Acid Therapeutics is an authoritative, peer-reviewed journal published bimonthly in print and online that focuses on cutting-edge basic research, therapeutic applications, and drug development using nucleic acids or related compounds to alter gene expression. Nucleic Acid Therapeutics is the Official Journal of the Oligonucleotide Therapeutics Society. Complete tables of content and a free sample issue may be viewed on the Nucleic Acid Therapeutics website.
About the Society
The Oligonucleotide Therapeutics Society is an open, nonprofit forum to foster academia and industry-based research and development of oligonucleotide therapeutics. The society brings together the expertise from different angles of oligonucleotide research to create synergies and to bring the field of oligonucleotides to its full therapeutic potential.
About the Publisher
Mary Ann Liebert, Inc. publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Human Gene Therapy and Human Gene Therapy Methods, Genetic Testing and Molecular Biomarkers, ASSAY and Drug Development Technologies, and DNA and Cell Biology. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 70 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc. publishers website.
Mary Ann Liebert, Inc. 140 Huguenot St., New Rochelle, NY 10801-5215
Phone: (914) 740-2100 (800) M-LIEBERT Fax: (914) 740-2101
http://www.liebertpub.com
New therapeutic strategy targets dengue virus using artificial microRNAs
2013-07-11
ELSE PRESS RELEASES FROM THIS DATE:
Buying behavior can be swayed by cultural mindset
2013-07-11
There are some combinations that just go well together: Milk and cookies, eggs and bacon, pancakes and maple syrup. But new research reveals that people with individualistic mindsets differ from their collectivist counterparts in ascribing value to those perfect combinations.
The collection of new studies, published in Psychological Science, a journal of the Association for Psychological Science, demonstrate that people with collectivist mindsets tend to value the relationships between items more than the particular items themselves. People with individualistic mindsets, ...
Training program meets 'critical need' for earlier autism identification
2013-07-11
A Vanderbilt research program that trains community pediatricians to diagnose autism within their individual practices may lead to more effective treatment of the disorder that now affects an estimated one in 88 children.
Vanderbilt University Medical Center researchers released today in the journal Autism the results of a three-year study that evaluated the effectiveness of a training program designed to enhance autism spectrum disorder (ASD) identification and assessment within community pediatric settings across Tennessee.
After participating in training to learn ...
3 neglected-disease treatments newly added to WHO Essential Medicines List for paediatric use
2013-07-11
[Geneva, Switzerland – 11 July 2013] – This week the World Health Organization (WHO) released its newly updated 4th WHO Model List of Essential Medicines for Children (EMLc), in which three treatments developed by the Drugs for Neglected Diseases initiative (DNDi) and its partners have now been included. One treatment was also added to the 18th WHO Model List of Essential Medicines (EML) for adults.
Artesunate-mefloquine fixed-dose combination (ASMQ FDC) was added to the EMLc for the treatment of malaria in children, and to the EML for adults, in line with current ...
People with Alzheimer's disease may have lower risk of cancer and vice versa
2013-07-11
MINNEAPOLIS – Older people with Alzheimer's disease are less likely to also have cancer, and older people with cancer are less likely to also have Alzheimer's disease, according to the largest study to date on the topic, which appears in the July 10, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology.
"Since the number of cases of both Alzheimer's disease and cancer increase exponentially as people age, understanding the mechanisms behind this relationship may help us better develop new treatments for both diseases," said study ...
Personality differences linked to later drinking have roots in early childhood
2013-07-11
Contact: Frances Dumenci, MS, APR
fdumenci@vcu.edu
804-828-7701
Virginia Commonwealth University
Matt McGue, Ph.D.
mmcgue001@umn.edu
612-625-8305
University of Minnesota
Alcoholism: Clinical & Experimental Research
Personality differences linked to later drinking have roots in early childhood
An individual enters adolescence with personality characteristics and life experiences already accumulated.
A new study evaluates the impact of childhood temperament on later alcohol use/problems.
Results show that childhood temperament prior to age five predicts ...
'Wasted' and 'hammered' versus 'buzzed' and 'tipsy' is more than just semantics
2013-07-11
Contact: Ash Levitt
alevitt@ria.buffalo.edu
716-887-3366
University at Buffalo, SUNY
Mark Wood
mark_wood@uri.edu
401-874-4252
University of Rhode Island
Alcoholism: Clinical & Experimental Research
'Wasted' and 'hammered' versus 'buzzed' and 'tipsy' is more than just semantics
Prior research found that women tended to use moderate self-referral terms for intoxication, whereas men used heavy terms.
New findings confirm that men's drinking is generally described in terms indicative of excessive consumption while women tend to couch drinking in more moderate ...
The brain's response to sweets may indicate risk for development of alcoholism
2013-07-11
Contact: David A. Kareken
dkareken@iupui.edu
317-274-7327
Indiana University School of Medicine
Alcoholism: Clinical & Experimental Research
The brain's response to sweets may indicate risk for development of alcoholism
Several human and animal studies have shown a relationship between a preference for highly sweet tastes and alcohol use disorders. Furthermore, the brain mechanisms of sweet-taste responses may share common neural pathways with responses to alcohol and other drugs. A new study using functional magnetic resonance imaging (fMRI) has found ...
Kids' allergies may correlate with omega-3, omega-6 lipid levels in cord blood
2013-07-11
Children with high proportions of poly-unsaturated fatty acids (PUFA) in cord blood at birth are more likely to develop respiratory and skin allergies in their early teens, according to research published July 10 in the open access journal PLOS ONE by Malin Barman and colleagues from the Chalmers University of Technology, Sweden.
The researchers followed nearly 800 children born in 1996-97 for diagnosis of allergies at age 13, and studied a subset of 44 who were diagnosed with respiratory allergies, 37 with chronic skin rashes and 48 who did not suffer allergies. Cord ...
Same beat set to different tunes changes walkers' pace
2013-07-11
Personal tastes in music have little to do with how we keep time to a tune while walking, according to research published July 10 by Marc Leman and colleagues from Ghent University, Belgium in the open access journal PLOS ONE.
Most people synchronize their steps to the beat of their tunes when they listen to music on a walk. In the current study, researchers found that even when excerpts of music had identical tempo and beat, other acoustic features influenced walkers' stride and speed.
Participants in the study heard samples of 52 different types of music that all ...
Typhoid's lethal secret revealed
2013-07-11
Typhoid fever is one of the oldest documented diseases known to have afflicted mankind but what makes it so lethal has remained a mystery for centuries. In a study appearing online July 10 in the journal Nature, Yale researchers offer an explanation of how the devastating disease marked by delirium and stupor still kills 200,000 people every year - and also suggests the basis of a future vaccine.
The culprit appears to be a powerful toxin possessed by Salmonella typhi, the bacterium that causes typhoid fever. Yale scientists for the first time describe the structure of ...